E coli vaccine (Novavax)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameE coli vaccine (Novavax)
Drug Alias NameShigella vaccine (Novavax)diarrhea vaccine (Novavax)
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsEscherichia coli InfectionsDysentery, Bacillary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNovavax Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovavax IncGlaxosmithkline Biologicals SA
Active IndicationsN/A
Inactive IndicationsEscherichia coli InfectionsDysentery, Bacillary

Other Information

ATC CodeN/A
Related LinksN/A